“Senolytic Therapeutics: Translating a Compelling Mouse Phenotype Into a Testable Human Endpoint”. Translational Medicine & Therapeutics Journal, vol. 2, no. 1, Feb. 2023, pp. 10-18, https://doi.org/10.5281/zenodo.22649028.